The benefits of soluble non-bacterial fraction of kefir on blood pressure and cardiac hypertrophy in hypertensive rats are mediated by an increase in baroreflex sensitivity and decrease in angiotensin-converting enzyme activity.

[1]  C. Zhang,et al.  Combinative effect of sardine peptides and quercetin alleviates hypertension through inhibition of angiotensin I converting enzyme activity and inflammation. , 2017, Food research international.

[2]  A. Cicero,et al.  Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review , 2017, British journal of pharmacology.

[3]  A. Pihlanto,et al.  Health benefits of fermented foods: microbiota and beyond. , 2017, Current opinion in biotechnology.

[4]  J. Tomek,et al.  Hypertension‐induced remodelling: on the interactions of cardiac risk factors , 2017, The Journal of physiology.

[5]  D. Lenz,et al.  Chronic administration of the soluble, nonbacterial fraction of kefir attenuates lipid deposition in LDLr-/- mice. , 2017, Nutrition.

[6]  Ł. Grześkowiak,et al.  Milk kefir: nutritional, microbiological and health benefits , 2017, Nutrition Research Reviews.

[7]  C. Schultz,et al.  Device Therapies for Resistant Hypertension. , 2016, Clinical therapeutics.

[8]  E. M. Dantas,et al.  Effects of Kefir on the Cardiac Autonomic Tones and Baroreflex Sensitivity in Spontaneously Hypertensive Rats , 2016, Front. Physiol..

[9]  K. Kalanetra,et al.  Peptidomic analysis reveals proteolytic activity of kefir microorganisms on bovine milk proteins. , 2016, Food chemistry.

[10]  S. Mohapatra,et al.  Milk derived bioactive peptides and their impact on human health – A review , 2015, Saudi journal of biological sciences.

[11]  C. Arpini,et al.  Chronic administration of the probiotic kefir improves the endothelial function in spontaneously hypertensive rats , 2015, Journal of Translational Medicine.

[12]  C. Soccol,et al.  Milk kefir: composition, microbial cultures, biological activities, and related products , 2015, Front. Microbiol..

[13]  J. Mill,et al.  Renal Effects and Underlying Molecular Mechanisms of Long-Term Salt Content Diets in Spontaneously Hypertensive Rats , 2015, PloS one.

[14]  D. Lenz,et al.  Cardiopulmonary reflex, cardiac cytokines, and nandrolone decanoate: response to resistance training in rats. , 2015, Canadian journal of physiology and pharmacology.

[15]  R. Hoffmann,et al.  Peptide profiling of bovine kefir reveals 236 unique peptides released from caseins during its production by starter culture or kefir grains. , 2015, Journal of proteomics.

[16]  S. Oparil,et al.  New approaches in the treatment of hypertension. , 2015, Circulation research.

[17]  D. Lenz,et al.  Antihypertensive Effect of Carica papaya Via a Reduction in ACE Activity and Improved Baroreflex , 2014, Planta Medica.

[18]  Jaykaran Charan,et al.  How to calculate sample size in animal studies? , 2013, Journal of pharmacology & pharmacotherapeutics.

[19]  D. Endringer,et al.  Nandrolone decanoate determines cardiac remodelling and injury by an imbalance in cardiac inflammatory cytokines and ACE activity, blunting of the Bezold–Jarisch reflex, resulting in the development of hypertension , 2013, Steroids.

[20]  Á. Gava,et al.  Baroreflex control of renal sympathetic nerve activity in mice with cardiac hypertrophy , 2012, Autonomic Neuroscience.

[21]  T. Coffman,et al.  Recent advances involving the renin–angiotensin system , 2012, Experimental Cell Research.

[22]  D. Harrison,et al.  Vascular Inflammatory Cells in Hypertension , 2012, Front. Physio..

[23]  Chibuike C. Udenigwe,et al.  Food protein-derived bioactive peptides: production, processing, and potential health benefits. , 2012, Journal of food science.

[24]  D. Lenz,et al.  Role of the renin-angiotensin system in the nandrolone-decanoate-induced attenuation of the Bezold-Jarisch reflex. , 2011, Canadian journal of physiology and pharmacology.

[25]  R. Touyz,et al.  A new look at the renin–angiotensin system—Focusing on the vascular system , 2011, Peptides.

[26]  M. Drazner.  Contemporary Reviews in Cardiovascular Medicine The Progression of Hypertensive Heart Disease , 2011 .

[27]  B. Cowan,et al.  Left ventricular hypertrophy and renin-angiotensin system blockade , 2009, Current hypertension reports.

[28]  E. Lazartigues,et al.  Angiotensin II Type 1 Receptor–Mediated Reduction of Angiotensin-Converting Enzyme 2 Activity in the Brain Impairs Baroreflex Function in Hypertensive Mice , 2009, Hypertension.

[29]  B. Pan,et al.  Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of milk , 2008 .

[30]  Gabriel Vinderola,et al.  Effects of kefir fractions on innate immunity. , 2006, Immunobiology.

[31]  I. Recio,et al.  Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. , 2005, Journal of dairy science.

[32]  J. Osborn,et al.  A neural set point for the long-term control of arterial pressure: beyond the arterial baroreceptor reflex. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[33]  O. Bakoush,et al.  Increased glomerular albumin permeability in old spontaneously hypertensive rats. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  I. Recio,et al.  Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. , 2004, Journal of agricultural and food chemistry.

[35]  E. Olson,et al.  Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.

[36]  H. Mauad,et al.  Neural reflex regulation of arterial pressure in pathophysiological conditions: interplay among the baroreflex, the cardiopulmonary reflexes and the chemoreflex. , 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[37]  G. Mancia,et al.  Baroreflex impairment by low sodium diet in mild or moderate essential hypertension. , 1997, Hypertension.

[38]  G. Head.  Baroreflexes and Cardiovascular Regulation in Hypertension , 1995, Journal of cardiovascular pharmacology.

[39]  I. Reid.  Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. , 1992, The American journal of physiology.

[40]  J. García-Estañ,et al.  Role of renin-angiotensin system in the impairment of baroreflex control of heart rate in renal hypertension. , 1991, Journal of hypertension.

[41]  J. Hall.  Control of blood pressure by the renin‐angiotensin‐aldosterone system , 1991, Clinical cardiology.

[42]  L. Feld,et al.  Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat. , 1977, Kidney international.